文献

J-GLOBAL ID：201802233731935614   整理番号：18A0731142

生物学的処理で臨床的寛解を達成した関節リウマチ患者における不十分な応答による生物学的中断の予測因子:多施設観察コホート研究

Predictors of biologic discontinuation due to insufficient response in patients with rheumatoid arthritis who achieved clinical remission with biologic treatment: A multicenter observational cohort study

著者 (21件)： ASAI Shuji (Nagoya Univ. Graduate School of Medicine, Aichi, JPN) ,  FUJIBAYASHI Takayoshi (Konan Kosei Hospital, Aichi, JPN) ,  OGUCHI Takeshi (Anjo Kosei Hospital, Aichi, JPN) ,  HANABAYASHI Masahiro (Ichinomiya Municipal Hospital, Aichi, JPN) ,  HAYASHI Masatoshi (Nagano Red Cross Hospital, Nagano, JPN) ,  MATSUBARA Hiroyuki (Nagano Red Cross Hospital, Nagano, JPN) ,  ITO Takayasu (Ito Orthopedic Clinic, Aichi, JPN) ,  YABE Yuichiro (Tokyo Shinjuku Medical Center, Tokyo, JPN) ,  WATANABE Tsuyoshi (Kariya-Toyota General Hospital, Aichi, JPN) ,  HIRANO Yuji (Toyohashi Municipal Hospital, Aichi, JPN) ,  KANAYAMA Yasuhide (Toyota Kosei Hospital, Aichi, JPN) ,  KANEKO Atsushi (Nagoya Medical Center, Aichi, JPN) ,  KATO Takefumi (Kato Orthopedic Clinic, Aichi, JPN) ,  TAKAGI Hideki (Nagoya Central Hospital, Aichi, JPN) ,  TAKAHASHI Nobunori (Nagoya Univ. Graduate School of Medicine, Aichi, JPN) ,  FUNAHASHI Koji (Nagoya Univ. Graduate School of Medicine, Aichi, JPN) ,  TAKEMOTO Toki (Nagoya Univ. Graduate School of Medicine, Aichi, JPN) ,  ASAI Nobuyuki (Nagoya Univ. Graduate School of Medicine, Aichi, JPN) ,  WATANABE Tatsuo (Nagoya Univ. Graduate School of Medicine, Aichi, JPN) ,  ISHIGURO Naoki (Nagoya Univ. Graduate School of Medicine, Aichi, JPN) ,  KOJIMA Toshihisa (Nagoya Univ. Graduate School of Medicine, Aichi, JPN)
資料名： Modern Rheumatology  (Modern Rheumatology)
巻： 28  号： 2  ページ： 221-226  発行年： 2018年03月 
JST資料番号： L5142A  ISSN： 1439-7595  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： イギリス (GBR)  言語： 英語 (EN)

抄録/ポイント： ・生物製剤によって臨床的寛解を達成した関節リウマチ患者におけ...

シソーラス用語： ヒト ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0731142&from=J-GLOBAL&jstjournalNo=L5142A") }}

分類 (1件)： 運動器系疾患の薬物療法  (GG05020D)

引用文献 (19件)：

• Prince FH, Bykerk VP, Shadick NA, Lu B, Cui J, Frits M, et al. Sustained rheumatoid arthritis remission is uncommon in clinical practice. Arthritis Res Ther. 2012;14:R68.
• Kuijper TM, Lamers-Karnebeek FB, Jacobs JW, Hazes JM, Luime JJ. Flare rate in patients with rheumatoid arthritis in low disease activity or remission when tapering or stopping synthetic or biologic DMARD: a systematic review. J Rheumatol. 2015;42:2012-22.
• Smolen JS, Nash P, Durez P, Hall S, Ilivanova E, Irazoque-Palazuelos F, et al. Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial. Lancet. 2013;381:918-29.
• Smolen JS, Emery P, Fleischmann R, van Vollenhoven RF, Pavelka K, Durez P, et al. Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial. Lancet. 2014;383:321-32.
• Tanaka Y, Hirata S, Kubo S, Fukuyo S, Hanami K, Sawamukai N, et al. Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study. Ann Rheum Dis. 2015;74:389-95.

タイトルに関連する用語 (12件)： 生物学的処理 ,  臨床的寛解 ,  関節リウマチ ,  患者 ,  応答 ,  生物学 ,  中断 ,  予測因子 ,  施設 ,  観察 ,  コホート ,  研究